Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Anti-Saccharomyces cerevisiae antibody (ASCA) positivity is associated with increased risk for early surgery in Crohn's disease.

Gut - 1 Aug 2004

Forcione D G, Rosen M J, Kisiel J B, Sands B E

Abstract excerpt

BACKGROUND: Anti-Saccharomyces cerevisiae antibodies (ASCA) are a specific but only moderately sensitive diagnostic marker for Crohn's disease. We sought to explore the role of ASCA as a prognostic marker for aggressive disease phenotype in Crohn's disease. AIMS: To determine the role of ASCA status as a risk factor for early surgery in Crohn's disease. SUBJECTS: We performed a case control study in a cohort of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antibodies, Antineutrophil Cytoplasmic
Share to Antibodies, Fungal

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Biomarkers

Share to Crohn Disease

Share to Immunoglobulin A

Share to Immunoglobulin G

Share to Porins

Share to Saccharomyces cerevisiae

Source

Open in PubMed Open full text

Identifiers

PMID: 15247177
DOI: 10.1136/gut.2003.030734
PMCID: PMC1774147

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Anti-Saccharomyces cerevisiae antibody (ASCA) positivity is associated with increased risk for early surgery in Crohn's disease.PMID 15247177Read ↗

Anti-Saccharomyces cerevisiae antibodies associate with phenotypes and higher risk for surgery in Crohn's disease: a meta-analysis.Semantic proximity Read ↗

Anti-Saccharomyces cerevisiae antibodies status is associated with oral involvement and disease severity in Crohn disease.Semantic proximity Read ↗

Clinical significance of anti-Saccharomyces cerevisiae antibody (ASCA) in Korean patients with Crohn's disease and its relationship to the disease clinical course.Semantic proximity Read ↗

Higher titers of anti-Saccharomyces cerevisiae antibodies IgA and IgG are associated with more aggressive phenotypes in Romanian patients with Crohn's disease.Semantic proximity Read ↗

Anti-Saccharomyces cerevisiae antibodies (ASCA) in Crohn's disease are associated with disease severity but not NOD2/CARD15 mutations.Semantic proximity Read ↗

Variation of Gut Mucosal Microbiome With Anti‐Saccharomyces cerevisiae Antibody Status in Pediatric Crohn DiseaseSemantic proximity Read ↗

NOD2 mutations and anti-Saccharomyces cerevisiae antibodies are risk factors for Crohn's disease in African Americans.Semantic proximity Read ↗

Significance of anti-sacharomices cerevisiae antibodies (ASCA) in patients with inflammatory bowel diseases in Romania.Semantic proximity Read ↗

Isolated active ileitis: is it a mild subtype of Crohn's disease?Semantic proximity Read ↗

Negative association between smoking and anti-saccharomyces cerevisiae antibodies in Crohn's disease.Semantic proximity Read ↗

Anti-Microbial Antibody Response is Associated With Future Onset of Crohn's Disease Independent of Biomarkers of Altered Gut Barrier Function, Subclinical Inflammation, and Genetic Risk.Semantic proximity Read ↗

Anti-saccharomyces cerevisiae antibodies in patients with inflammatory bowel disease and their first-degree relatives: potential clinical value.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.